Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Biomedicines|March 29, 2023
Special Issue: Therapeutic Potential for Cannabis and CannabinoidsWesley M Raup-KonsavageBiomedicines|December 30, 2025
Special Issue: Therapeutic Potential for Cannabis and Cannabinoids 2.0Wesley M Raup-KonsavageCannabis and Cannabinoid Research|November 21, 2022
Potential Utility of Cannabidiol in Stress-Related DisordersNicole A Lookfong, Wesley M Raup-Konsavage, Yuval SilbermanThe Journal of Pharmacology and Experimental Therapeutics|November 10, 2020
The Pharmacological Case for CannabigerolRahul Nachnani, Wesley M Raup-Konsavage, Kent E VranaDigestive Diseases and Sciences|August 31, 2015
A Role for MYC in Lithium-Stimulated Repair of the Colonic Epithelium After DSS-Induced Damage in MiceWesley M Raup-Konsavage, Timothy K Cooper, Gregory S YochumMedical Cannabis and Cannabinoids|June 29, 2026
Pharmacokinetics of Cannabinoids Delivered by Diverse Routes in RodentsShivani S Godbole, Wesley M Raup-Konsavage, Kent E VranaPharmacology|January 30, 2022
Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based PharmaceuticalsChristopher A Legare, Wesley M Raup-Konsavage, Kent E VranaCell Cycle (Georgetown, Tex.)|February 7, 2015
A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cellsMeera Shah, Sherri A Rennoll, Wesley M Raup-Konsavage, et al.Biomedicines|October 27, 2022
Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic PainDiana E Sepulveda, Kent E Vrana, Nicholas M Graziane, et al.Plos One|October 28, 2020
Loss of p120ctn causes EGFR-targeted therapy resistance and failureMary E Landmesser, Wesley M Raup-Konsavage, Heather L Lehman, et al.Pageof 5